Bank Of America Corp Lexicon Pharmaceuticals, Inc. Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 107,088 shares of LXRX stock, worth $88,883. This represents 0.0% of its overall portfolio holdings.

Number of Shares

107,088

Previous 87,185 22.83%

Holding current value

$88,883

Previous $146,000 15.07%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.51 - $2.39 $30,053 - $47,568	19,903 Added 22.83%	107,088 $168,000
Q2 2024 Aug 14, 2024	BUY	$1.54 - $2.28 $2,022 - $2,993	1,313 Added 1.53%	87,185 $146,000
Q1 2024 May 15, 2024	SELL	$1.3 - $3.58 $162,308 - $446,973	-124,853 Reduced 59.25%	85,872 $206,000
Q4 2023 Feb 14, 2024	BUY	$1.0 - $1.53 $132,433 - $202,622	132,433 Added 169.15%	210,725 $322,000
Q2 2023 Aug 14, 2023	BUY	$2.15 - $3.49 $37,691 - $61,183	17,531 Added 28.85%	78,292 $179,000
Q1 2023 May 12, 2023	SELL	$1.99 - $2.68 $3,402 - $4,582	-1,710 Reduced 2.74%	60,761 $147,000
Q4 2022 Feb 10, 2023	SELL	$1.8 - $2.56 $85,791 - $122,014	-47,662 Reduced 43.28%	62,471 $119,000
Q3 2022 Nov 14, 2022	BUY	$1.94 - $3.43 $139,336 - $246,352	71,823 Added 187.48%	110,133 $264,000
Q2 2022 Aug 12, 2022	SELL	$1.31 - $2.69 $11,011 - $22,612	-8,406 Reduced 17.99%	38,310 $71,000
Q1 2022 May 16, 2022	SELL	$1.95 - $3.89 $448,123 - $893,949	-229,807 Reduced 83.11%	46,716 $97,000
Q4 2021 Feb 08, 2022	BUY	$3.81 - $6.16 $981,132 - $1.59 Million	257,515 Added 1354.77%	276,523 $1.09 Million
Q3 2021 Nov 15, 2021	SELL	$3.38 - $5.35 $48,124 - $76,173	-14,238 Reduced 42.83%	19,008 $91,000
Q2 2021 Sep 13, 2021	BUY	$4.12 - $5.87 $136,973 - $195,154	33,246 New	33,246 $153,000

Others Institutions Holding LXRX

# of Institutions

141

Shares Held

238M

Call Options Held

459K

Put Options Held

133K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Lexicon Pharmaceuticals, Inc. Transaction History